Two days to a working application. Three minutes to a live hotfix. Fifty thousand lines of code with comprehensive tests.

Veeva Systems Inc. (NYSE:VEEV) made a significant announcement on January 29 when it unveiled Veeva eSource, a new application within its SiteVault platform designed to improve data accuracy and ...

Veeva Systems (VEEV) is drawing fresh attention after a sharp pullback in information technology stocks tied to fears of artificial intelligence disruption, even as new life sciences customers ...

PLEASANTON, Calif., Feb. 4, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that 13 of the top 20 biopharmas have standardized on Veeva Link Key People to enhance customer engagement ...

Veeva Systems Inc Class A stock reached a 52-week low of $201.51, marking a significant point in its trading history. Over the past year, Veeva Systems has experienced a decline in its stock value, ...

PLEASANTON, Calif., Jan. 29, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva eSource, a new Veeva SiteVault application designed to significantly reduce manual clinical trial ...

As noted previously, when Veeva ended its licence agreement with Salesforce, it not only triggered a battle royale for domination of big pharma CRM, it began the first massive use case for adoption of ...

The latest announcement is out from Veeva Systems ( (VEEV)). On January 5, 2026, Veeva Systems announced that its board had authorized the company’s first-ever share repurchase program, allowing the ...

The Details: Veeva reported quarterly earnings of $2.04 per share, which beat the analyst estimate of $1.95. Quarterly revenue of $811.2 million beat the Street estimate of $792.82 million.

Veeva Systems delivered strong Q2 results, with robust revenue growth and a fortress-like balance sheet, reinforcing its leadership in the biopharma sector. The company resolved its legal dispute with ...